Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Change in Inventory (2023 - 2025)

Historic Change in Inventory for Evoke Pharma (EVOK) over the last 3 years, with Q3 2025 value amounting to -$41964.0.

  • Evoke Pharma's Change in Inventory rose 1828.96% to -$41964.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $110420.0, marking a year-over-year increase of 105875.66%. This contributed to the annual value of -$32839.0 for FY2024, which is 11706.26% down from last year.
  • As of Q3 2025, Evoke Pharma's Change in Inventory stood at -$41964.0, which was up 1828.96% from $109727.0 recorded in Q2 2025.
  • Evoke Pharma's Change in Inventory's 5-year high stood at $148845.0 during Q2 2023, with a 5-year trough of -$51357.0 in Q3 2024.
  • Moreover, its 3-year median value for Change in Inventory was -$8787.0 (2023), whereas its average is $28586.4.
  • Its Change in Inventory has fluctuated over the past 5 years, first tumbled by 48446.57% in 2024, then soared by 34931.72% in 2025.
  • Over the past 3 years, Evoke Pharma's Change in Inventory (Quarter) stood at -$23085.0 in 2023, then plummeted by 92.36% to -$44407.0 in 2024, then rose by 5.5% to -$41964.0 in 2025.
  • Its Change in Inventory stands at -$41964.0 for Q3 2025, versus $109727.0 for Q2 2025 and $87064.0 for Q1 2025.